181 results
Page 3 of 10
6-K
EX-99.1
v8mmc9
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
EX-99.2
9g5n7s633krg 5t3kv
29 Aug 22
Current report (foreign)
4:00pm
6-K
EX-99.1
gneikmi t3
29 Aug 22
Current report (foreign)
4:00pm
6-K
eci63fq6
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-10.4
xppie
8 Jul 22
Current report (foreign)
8:58am
6-K
lkh vdu9hc
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-2.1
sgmzqb
8 Jul 22
Current report (foreign)
8:58am
6-K
l0w krqqt
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
20-F/A
gu1w396j82zq43oc3b1
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
EX-99.1
8y2bvmqk9tw3zp5g
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
vujeyp 6rh5wvk8r79z
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
8pyftav clj9
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
19nxfz3c5l5e
30 Aug 21
Current report (foreign)
5:21pm